Researchers studied whether a dance intervention may be beneficial for adolescents with autism spectrum disorder.
The safety profile of Orkambi was found to be similar in patients aged 1 to less than 2 years compared with those 2 years of age and older.
Researchers sought to evaluate the risk for hearing loss with outpatient use of oral macrolide therapy in children, adolescents, and young adults.
Lomecel-B is delivered via intramyocardial injection.
Researchers compared the effects of amoxicillin with other broad-spectrum antibiotics on the risk for treatment failure and reinfection in children with uncomplicated acute otitis media.
Researchers sought to determine the long-term durability of CBIT in youth with Tourette syndrome and persistent motor or vocal tic disorders.
Dialysis facility profit status was associated with longer time to waitlisting and kidney transplantation, investigators reported.
Most parents of young children eligible for COVID-19 vaccines said they are reluctant to get them vaccinated, including 43% who say they will “definitely not” do so.
Researchers examined changes in fecal metabolites resulting from either the Crohn disease exclusion diet plus enteral nutrition or the exclusive enteral nutrition diet and the association with remission.
The approval is supported by evidence from adequate and well-controlled studies of Stelara.
Deborah Goldman, MD, and Kara Gross Margolis, MD, discuss the importance of understanding gastrointestinal symptoms in children with autism to drive better care.
The approval was based on data from the phase 3 Marigold study that included patients aged 2 to 19 years with genetically confirmed CDKL5 gene mutation.
The main focus of the debate surrounding pediatric bipolar disorder pertains to the concept of a prepubertal subtype of the disorder.
Researchers sought to assess OSA symptoms and age of OSA diagnosis in children with and without ASD.
Researchers sought to investigate the factors that may modify the association between neurodevelopmental disorders and the risk for being bullied.
A 14-year-old adolescent with epilepsy presents with increasing episodes of nosebleeds, increased rate of speech, leg pain with little exercise, and irritable mood. Learn how delayed diagnosis of Graves disease affected her treatment.
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
Researchers used data from a European sample of teens from the IMAGEN Consortium study, which measured resting-state fMRI activity at age 14, 16, and 18.
In a cross-sectional study, researchers explored the co-occurrence for motor and language impairments in children evaluated for autism.